Business Wire

Prometheus Slashes Cost of Carbon Capture by More Than 80%, Unlocking Affordable E-Fuels as a New Source of 24/7 Carbon Neutral Power

15.9.2025 11:00:00 EEST | Business Wire | Press release

Share

Prometheus Fuels (Prometheus), the company producing low-cost carbon neutral fuels from direct air capture and renewable electricity, today announced it has achieved the lowest-cost carbon capture in the world, reducing the cost of Direct Air Capture (DAC) by more than 80 percent compared to industry averages. At under $50 per ton, Prometheus’ DAC cost breakthrough unlocks carbon neutral fuels at fossil fuel prices, without relying on subsidies, biogenic carbon, or point-source emissions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915079297/en/

Prometheus builds a 200-ton-per-year Direct Air Capture system at its California HQ, adding capacity to its currently operating 16-TPY system, the world’s lowest-cost DAC technology at less than $50 per ton CO₂.

The achievement is demonstrated in Prometheus’ new 200-ton-per-year DAC system, currently under construction and scheduled for completion this year. The system captures CO₂ directly from ambient air into water and feeds it into the company’s patented Faraday Reactor for immediate conversion into fuel. This streamlined approach bypasses traditional gas purification, compression, absorption and desorption, and costly infrastructure –dramatically reducing both energy use and capital requirements.

The announcement comes as policymakers, investors, and major emitters race to identify new carbon neutral power sources. With subsidy-driven approaches under pressure and most carbon capture technologies still too expensive to scale, Prometheus’ breakthrough offers a commercially ready, cost-competitive, new source of power – liquid fuels made from solar that can provide 24/7 carbon neutral electricity, propulsion, and heat anywhere in the world.

“Low-cost DAC unlocks the best solar locations, far away from point sources of CO2” said Rob McGinnis, founder and CEO of Prometheus. “By developing a new low-cost DAC technology, along with our hydrocarbon electrolysis Faraday Reactor, we’ve brought carbon capture below $50 a ton and made truly affordable e-fuels possible for the first time.”

Most DAC systems cost between $200 and $600 per ton of CO₂ captured, making it virtually impossible to produce synthetic fuels that compete with fossil fuel prices. Prometheus’ breakthrough slashes that cost by more than 80 percent, offering the first commercially viable model for scalable, carbon neutral fuel production.

Unlike conventional e-fuel approaches that rely on smokestacks or bio-derived CO₂, Prometheus’ modular, off-grid system gives it full geographic and economic flexibility. By decoupling fuel production from traditional carbon sources, Prometheus can site its systems wherever renewable electricity is cheapest, and inexpensively transport liquid fuels anywhere in the world.

“This isn’t just a scientific breakthrough, it’s a whole new business model,” added McGinnis. “When you combine ultra-low-cost DAC with modular, off-grid electrochemical fuel production, you open up access to remote, off-grid solar – the cheapest source of energy on the planet – making it available anywhere in the world as a new low-cost source of 24/7, firm, dispatchable, carbon neutral power.”

The company’s DAC costs and fuel economics were independently validated by Ramboll, a global engineering firm, in a detailed techno-economic analysis of Prometheus’ full production process.

Prometheus has operated the world’s only commercial-scale DAC prototype for more than four years. That system is actively producing e-fuels at the company’s Titan Forge Alpha pilot plant today. The new modular 200-ton system builds on this proven platform to scale production and meet growing demand from sectors including AI power, factories, green steel, aviation, shipping, and cities, where this new source of carbon neutral power can stabilize the grid by fueling peaker and baseload plants.

To see a demo of Prometheus fuel made from DAC and solar at the company’s Titan Forge Alpha pilot plant, visit: https://bit.ly/Promethean-Stang-Reveal

About Prometheus Fuels

Prometheus is the global leader in carbon neutral fuels made from direct air capture and renewable electricity to power AI data centers, factories, ships, vehicles, and aircraft. The company’s patented technology produces fuel at fossil fuel prices without subsidies, transforming energy production. Designed to run off-grid, Prometheus offers a scalable source of new power, transforming intermittent renewable energy into firm dispatchable 24/7 power, anywhere it is needed. Backed by top-tier investors including Maersk, BMW, Y Combinator, Paul Graham, Jaan Tallinn, John and Patrick Collison, Garrett Camp, and Tom Preston-Werner, Prometheus is redefining the future of energy. Learn more at prometheusfuels.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250915079297/en/

Contacts

Media Contacts:
Nickell Communications for Prometheus Fuels:
prometheus@nickellcommunications.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences23.9.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin longevity and evidence-based care. “At Galderma, we recognize that advancing dermatology means not only addressing the needs of patients living with common chronic skin conditions, such as atopic dermatitis and acne, but also anticipating the trends that will shape the future of skin health. Our presence at EADV demonstrates our unique ability to achieve this, with new data spanning both established areas of unmet need and emerging fields such as skin longevity, helping drive innovation and meaningful outcomes for patients today and i

Oticon Medical Launches SmartCharger for the Ponto 5 Family23.9.2026 08:00:00 EEST | Press release

Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922863462/en/ Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. Powering the Ponto 5 family The launch of SmartCharger underlines Oticon Medical’s continued commitment to the Ponto family, which includes Ponto 5 SuperPower, the world’s most powerful abutment-level sound processor,1 and Ponto 5 Mini, the world’s smallest percutaneous sound processor.1 By bringing rechargeable convenience to the Ponto sound processors, Oticon Me

Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release

Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone

OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release

OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye